OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, and Scipher Medicine, which ...

Those who finished at-least 5 years followed up were eligible in this study. Clinical data, including RA disease activity (DAS28-ESR, DAS28-ESR, SDAI and CDAI) and physical function indicator (HAQ-DI) ...

With nearly 30% of patients enrolled in each arm having a CDAI <150 at study entry ... comment on the risk of lymphoma with MTX cotreatment in IBD patients. Adult rheumatoid arthritis data show that ...

Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...

Adalimumab trough levels of 4.0 mg/L or higher among patients with RA were linked to greater treatment response and ...

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

Nurse-led care effectively reduces disease activity and improves self-efficacy in patients with rheumatoid arthritis, ...

Patients with rheumatoid arthritis who demonstrate consistent long-term elevation of inflammatory markers have an increased ...

Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...

HealthDay News — There is a bidirectional association between rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD), according to a review published online Dec. 1 in Frontiers in ...

High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.